Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey L Bennett

Showing results (61-70 of 192) with videos related to

Pageof 20
Sort By:
Acta Neuropathologica Communications|June 12, 2025
Complement inhibition rapidly blocks lesion extension and facilitates remyelination in neuromyelitis opticaKatherine S Given, Elizabeth G Acker, Wendy B Macklin, et al.
Clinical & Experimental Neuroimmunology|November 15, 2016
Evaluation of aquaporin-4 antibody assaysPatrick J Waters, Sean J Pittock, Jeffrey L Bennett, et al.
Ophthalmology|June 9, 2015
Varicella Zoster Virus in Ischemic Optic NeuropathyLiliya Golas, Jeffrey L Bennett, Teresa M White, et al.
Journal of Neuroimmunology|November 13, 2007
Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blastsKimberly M Winges, Donald H Gilden, Jeffrey L Bennett, et al.
Neurology|May 3, 2013
Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritisMaria A Nagel, Jeffrey L Bennett, Nelly Khmeleva, et al.
European Journal of Immunology|January 7, 2017
Deletional tolerance prevents AQP4-directed autoimmunity in miceAnna-Lena Vogel, Benjamin Knier, Katja Lammens, et al.
Journal of Neuroinflammation|December 2, 2016
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis opticaYiting Liu, Danielle E Harlow, Katherine S Given, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 1, 2020
Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis PatientsM C Kowarik, D Astling, G Lepennetier, et al.
Experimental Neurology|April 29, 2019
Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivoYiting Liu, Katherine S Given, Erin L Dickson, et al.
Science Advances|February 21, 2025
Structural basis of aquaporin-4 autoantibody binding in neuromyelitis opticaMeghna Gupta, Nitesh Kumar Khandelwal, Andrew Nelson, et al.
Pageof 20

Showing results (61-70 of 192) with videos related to

Sort By:
Pageof 20
Acta Neuropathologica Communications|June 12, 2025
Complement inhibition rapidly blocks lesion extension and facilitates remyelination in neuromyelitis opticaKatherine S Given, Elizabeth G Acker, Wendy B Macklin, et al.
Clinical & Experimental Neuroimmunology|November 15, 2016
Evaluation of aquaporin-4 antibody assaysPatrick J Waters, Sean J Pittock, Jeffrey L Bennett, et al.
Ophthalmology|June 9, 2015
Varicella Zoster Virus in Ischemic Optic NeuropathyLiliya Golas, Jeffrey L Bennett, Teresa M White, et al.
Journal of Neuroimmunology|November 13, 2007
Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blastsKimberly M Winges, Donald H Gilden, Jeffrey L Bennett, et al.
Neurology|May 3, 2013
Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritisMaria A Nagel, Jeffrey L Bennett, Nelly Khmeleva, et al.
European Journal of Immunology|January 7, 2017
Deletional tolerance prevents AQP4-directed autoimmunity in miceAnna-Lena Vogel, Benjamin Knier, Katja Lammens, et al.
Journal of Neuroinflammation|December 2, 2016
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis opticaYiting Liu, Danielle E Harlow, Katherine S Given, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 1, 2020
Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis PatientsM C Kowarik, D Astling, G Lepennetier, et al.
Experimental Neurology|April 29, 2019
Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivoYiting Liu, Katherine S Given, Erin L Dickson, et al.
Science Advances|February 21, 2025
Structural basis of aquaporin-4 autoantibody binding in neuromyelitis opticaMeghna Gupta, Nitesh Kumar Khandelwal, Andrew Nelson, et al.
Pageof 20